ArticleAntimicrobial agents and chemotherapy2016

Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Caroline Schad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.